GlassScriptPhysician profile
Justin A Classie
NPI 1588896708
$38,151.06
in general payments reported to CMS, 2019-2025
11 companies · $544 in 2025
The $544 reported for 2025 was more than what 84% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $11K · 2021: $8,224 · 2022: $16.68 · 2023: $274 · 2024: $1,900 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,085 · Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,084.66 |
| Food and Beverage | $633.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $32,285.18 | 2019-2021 | |
| Arthrex, INC. | $3,712.97 | 2019-2025 | |
| Horizon Therapeutics Plc | $821.29 | 2019-2022 | |
| Depuy Synthes Sales INC. | $429.98 | 2019-2024 | Orthovisc |
| Suvon Surgical LLC | $392.12 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $168.22 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $148.95 | 2019-2023 | Euflexxa |
| Fidia Pharma USA INC. | $117.20 | 2019-2020 | |
| Orthofix Medical, INC. | $45.42 | 2019 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Bioventus LLC | $13.92 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Classie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.